Global Kidney Function Tests Market, By Test Type (Dilution and Concentration Tests, Clearance Tests, Urine Tests, Imaging Tests, Blood Test), Product Type (Dipsticks, Disposables, Reagents), End Use (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes) – Industry Trends and Forecast to 2029.
Kidney Function Tests Market Analysis and Size
Derangement of any of these functions would result in either decreased excretion of waste products and hence their accumulation in the body or loss of some vital nutrient from the body. Based on the level of these excretory products and nutrients in the urine as well as in blood, we could make an accurate calculation to decipher the efficiency of the kidney to undertake its various functions.
Data Bridge Market Research analyses that the kidney function tests market which was USD 823.68 million in 2021, is expected to reach USD 1,312.83 million by 2029, at a CAGR of 6.00% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Kidney Function Tests Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Test Type (Dilution and Concentration Tests, Clearance Tests, Urine Tests, Imaging Tests, Blood Test), Product Type (Dipsticks, Disposables, Reagents), End Use (Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott (U.S.), Akers Biosciences, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Home Access Health (U.S.), Laboratory Corporation of America Holdings (U.S.), PRIMA Lab SA (Switzerland), Quest Diagnostics Incorporated (U.S.), Randox Laboratories Ltd. (U.K.), Sekisui Diagnostics (U.S.), Siemens (Germany), Merck KGaA (Germany), Siemens Healthcare Private Limited (Germany), Danaher (U.S.), Sysmex Corporation (Japan), Nova Biomedical (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Kidney function tests are a group of lab tests that include urine analysis, blood urea nitrogen (BUN), and serum creatinine tests, among others, to examine the normal functioning of the kidneys. They are extremely useful in determining the normal functions of the renal tissues as well as detecting any abnormalities or health anomalies, such as acute/chronic kidney disease, polycystic kidney disease, diabetic nephropathy, kidney failure, and glomerulonephritis. Kidney function tests are blood tests or urine tests that evaluate how well your kidneys are working. Most of the tests measure glomerular filtration rate (GFR). Glomerular filtration rate assesses how efficiently your kidneys clear waste from your system. The main function of the kidney would be the excretion of water-soluble waste products from our body. The kidney has various filtration, excretion, and secretory functions. A group of tests that help to evaluate the function of kidneys to enable early diagnosis and prevention of worsening of disease. Wastes and excess fluid are removed from the blood by healthy kidneys. Blood and urine tests show how well the kidneys are working and how quickly wastes are removed from the body. Urine tests can also detect if the kidneys are leaking excessive amounts of protein, which is a sign of kidney damage.
Global Kidney Function Tests Market Dynamics
Drivers
- Technological innovations are driving the market
Rising innovation and technological advancement which is the first systems for treating kidney failure were developed in the 1940's, when it was found that blood could be successfully cleared of toxins and returned to the body using a relatively simple device based on artificial sausage skin wrapped around a wooden frame) will further increase a number of prospects that will drive the growth of the kidney function testing market throughout the course of the above mentioned forecast period.
- Development of novel products is also bolstering growth
Rising R&D initiatives for the development of novel products are expected to significantly boost market growth during the forecast period. For instance, in January 2020, Germany-based SphingoTec GmbH launched its IB10 sphingotest penKid, a Point-of-Care (PoC) test for Proenkephalin (penKid). This biomarker enables real-time evaluation of kidney function with a normal blood test. In addition, growing investments in the field of kidney function testing are further expected to fuel the market growth. In January 2020, Sweden-based Elypta AB raised a seed round worth USD 7.0 million to develop the first urine test for kidney cancer.
Opportunities
- Government initiatives
Several public-private partnerships are launching initiatives to make kidney disease testing more accessible in key areas. For instance, in July 2020, the National Kidney Foundation (NKF) introduced a new kidney health evaluation measure, specifically for diabetes patients, in collaboration with the National Committee for Quality Assurance (NCQA). The new guidelines recommend that diabetic patients be routinely tested for kidney disease. Such initiatives are expected to foster a favourable environment for market expansion.
Restraints/Challenges
- High cost of kidney related tests
High cost of kidney function tests and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate. The greater number of individuals with a clinical diagnosis of kidney disease as a result of the modified formula would mean that more people may receive recommendations for dose adjustments or contraindications for certain drugs that may interfere with kidney function or be poorly filtered by the kidneys.
This kidney function tests market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the kidney function tests market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent developments
- In August 2021, ID Genomics (IDG), a Seattle-based company, invented a dipstick-based assay for the simultaneous identification of a large number of genetic variants of SARS-CoV2 and received a grant of USD 300,000 from the National Institute of Health (NIH).
- In July 2022, bioMérieux received FDA approval for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in patients at risk of acute kidney injury (AKI). The introduction of new products and the region's growing advances in urine analysis are driving market growth.
Global Kidney Function Tests Market Scope
The kidney function tests market is segmented on the basis of test type, product type, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Test Type
- Dilution and Concentration Tests
- Clearance Tests
- Urine Tests
- Imaging Tests
- Blood Test
- Serum Creatinine Tests
- Blood Urea Nitrogen Tests
- Glomerular Filtration Rate Tests
Product Type
- Dipsticks
- Disposables
- Reagents
End Use
- Hospitals
- Diagnostic Laboratories
- Research Laboratories and Institutes
Kidney Function Tests Market Regional Analysis/Insights
The kidney function tests market is analysed and market size insights and trends are provided by country, test type, product type, end-user as referenced above.
The countries covered in the kidney function tests market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the kidney function tests market due to the high awareness levels about CKD, and favorable reimbursement policies and government initiatives. The U.S. accounted for the leading share in North America regional market. Key factors contributing to its dominance include the local presence of major market players and the easy availability of technologically advanced products.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rapidly developing healthcare facilities and an increase in investments by leading market players.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The kidney function tests market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for kidney function tests market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the kidney function tests market. The data is available for historic period 2010-2020.
Competitive Landscape and Kidney Function Tests Market Share Analysis
The kidney function tests market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to kidney function tests market.
Some of the major players operating in the kidney function tests market are:
- Abbott (U.S.)
- Akers Biosciences, Inc. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Boston Heart Diagnostics Corporation (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Home Access Health (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- PRIMA Lab SA (Switzerland)
- Quest Diagnostics Incorporated (U.S.)
- Randox Laboratories Ltd. (U.K.)
- Sekisui Diagnostics (U.S.)
- Siemens (Germany)
- Merck KGaA (Germany)
- Siemens Healthcare Private Limited (Germany)
- Danaher (U.S.)
- Sysmex Corporation (Japan)
- Nova Biomedical (U.S.)
SKU-